文献速递心律失常

多囊卵巢综合征与心律失常长期风险:丹麦全国匹配队列研究

Polycystic Ovarian Syndrome and the Long-Term Risk of Arrhythmias.
PubMed 文献 · Circulation · 2026-01-22

丹麦全国性匹配队列研究纳入1977—2024年诊断的多囊卵巢综合征(PCOS)女性26 728例及按年龄和索引年份1:4匹配的对照106 912例。PCOS患者25年心律失常累积风险为6.3%,高于对照的4.2%;调整后风险比1.48,且房室传导阻滞、心脏骤停、房颤/房扑及心脏植入式电子装置(CIED)植入风险均升高。

要点

  • PCOS女性长期心律失常风险较背景人群升高约48%,绝对事件率仍较低。
  • 房颤/房扑、晚期房室传导阻滞和心脏骤停风险均显著增加。
  • PCOS患者接受CIED植入的风险约为对照的1.85倍。

核心结论

  • PCOS女性较背景人群女性具有更高的长期心律失常发生风险和CIED植入率。
  • 尽管绝对事件率低,研究结果支持对PCOS患者早期进行心血管风险评估和预防策略。

研究设计与样本

  • 丹麦全国性匹配队列研究,PCOS诊断年份为1977—2024年。
  • 纳入26 728例PCOS女性(中位年龄27.8岁,IQR 23.7–32.1)和106 912例按年龄与索引年份1:4匹配的女性对照。

主要发现

  • PCOS组25年心律失常累积风险6.3%(95%CI 5.6–6.9),对照组4.2%(95%CI 3.9–4.5)。
  • 心律失常发生率分别为23.8(95%CI 22.1–25.6)和15.7(95%CI 15.0–16.4)/10 000人年,未调整HR 1.56(95%CI 1.43–1.71),调整后HR 1.48(95%CI 1.35–1.63)。
  • 亚型分析:晚期房室传导阻滞调整后HR 1.76(95%CI 1.05–2.93),心脏骤停调整后HR 1.44(95%CI 1.03–2.08),房颤/房扑调整后HR 1.44(95%CI 1.20–1.73)。
  • CIED植入发生率分别为1.9(95%CI 1.5–2.5)和1.1(95%CI 0.9–1.3)/10 000人年,调整后HR 1.85(95%CI 1.30–2.63)。
  • 上述风险升高独立于二甲双胍、口服避孕药、螺内酯、抗雄激素药物及GLP-1受体激动剂的使用。

临床怎么用

  • 对PCOS女性应重视心律失常相关症状评估和长期心血管风险监测。
  • PCOS患者若出现心悸、晕厥等症状,需警惕房颤/房扑或传导阻滞并及时检查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Polycystic ovarian syndrome (PCOS) is associated with increased cardiovascular morbidity and a higher risk of atherosclerotic cardiovascular disease. PCOS has been associated with electrocardiographic alterations. However, the potential long-term risk of cardiac arrhythmias in women with PCOS remains insufficiently investigated. METHODS: Women diagnosed with PCOS in Denmark (1977-2024) were matched on age and year of index with female controls from the background population (ratio 1:4). The primary outcome was incident arrhythmia, with subtype of arrhythmia and cardiac implantable electronic device (CIED, ie, pacemaker and cardioverter defibrillator implantation) implantation as secondary outcomes. Patients were followed from date of PCOS diagnosis until date of event, emigration, death, or end of study (January 31, 2024). RESULTS: The study included 26 728 women with PCOS (median age, 27.8 years [interquartile range, 23.7-32.1]) and 106 912 controls. Women with PCOS had a higher comorbidity burden and pharmacotherapy use compared with controls. The 25-year associated risk of arrhythmias was higher among women with PCOS (6.3% [95% CI, 5.6-6.9]) compared with controls (4.2% [95% CI, 3.9-4.5]), equivalent to incidence rates of 23.8 (95% CI, 22.1-25.6) and 15.7 (95% CI, 15.0-16.4) per 10 000 person-years, respectively, an unadjusted hazard ratio (HR) of 1.56 (95% CI, 1.43-1.71), and an adjusted HR of 1.48 (95% CI, 1.35-1.63). Across subtypes of arrhythmias, women with PCOS were associated with a higher risk of advanced atrioventricular block (adjusted HR, 1.76 [95% CI, 1.05-2.93]), cardiac arrest (adjusted HR, 1.44 [95% CI, 1.03-2.08]), and atrial fibrillation or flutter (adjusted HR, 1.44 [95% CI, 1.20-1.73]) compared with controls. Women with PCOS were more likely to receive a CIED compared with controls (incidence rates of 1.9 [95% CI, 1.5-2.5] and 1.1 [95% CI, 0.9-1.3] per 10 000 person-years, respectively; adjusted HR, 1.85 [95% CI, 1.30-2.63]). The higher associated risk of arrhythmias and likelihood of receiving a CIED among women with PCOS was independent of use of metformin, oral contraception, spironolactone, antiandrogens, and glucagon-like peptide receptor analogs. CONCLUSIONS: Women with PCOS had a higher associated long-term risk of developing arrhythmias and a higher incidence of receiving a CIED compared with female controls from the background population. Despite low absolute event rates, these findings emphasize the clinical relevance of early cardiovascular risk assessment and preventive strategies for patients diagnosed with PCOS.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Reinert MS, Ryde HV, Sørensen LM, et al. Polycystic Ovarian Syndrome and the Long-Term Risk of Arrhythmias. Circulation. 2026. PMID: 41568438. doi:10.1161/CIRCULATIONAHA.125.078039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。